Shingrix (Zoster vaccine recombinant, adjuvanted) NDC 58160-849

Product information

Brand name (proprietary)

Shingrix

Generic name (nonproprietary)

zoster vaccine recombinant, adjuvanted

Active ingredients

Recombinant varicella zoster virus glycoprotein e antigen — 50 ug/.5mL

Dosage form

Injection, Solution

Route

Intramuscular

Labeler

GlaxoSmithKline Biologicals SANDC labeler code 58160

Product type

Vaccine

Marketing category

BLA — Biologics License ApplicationApplication BLA 125614

Marketing start

Jul 16, 2025

Listing expires

Dec 31, 2027

Identifiers

Product ID 58160-849_844a535e-3d0e-46fe-b672-10605bedbb71SPL ID 844a535e-3d0e-46fe-b672-10605bedbb71

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeMed-Code curated

CPT 90750 — Vaccine product code for SHINGRIX (zoster vaccine recombinant, adjuvanted)

Billing unit: 1 dose. Units on the claim = dose given ÷ 1 dose.

Administration

Immunization administration (CPT 90460–90474)

Giving a vaccine is reported separately from the vaccine product code, with an immunization administration code. Which code applies depends on the patient's age, the route and whether counselling was provided.

How CPT relates to drug billing

NDC on a medical claim

N458160084952 followed by a unit qualifier and the quantity Copy

Package 58160-0849-52. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 58160-849

What is NDC 58160-849?

58160-849 is the product NDC for Shingrix, Recombinant varicella zoster virus glycoprotein e antigen 50 ug/.5mL injection, solution, listed with the FDA by GlaxoSmithKline Biologicals SA. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Shingrix (Zoster Vaccine Recombinant, Adjuvanted).

What is the active ingredient?

Recombinant varicella zoster virus glycoprotein e antigen.

Who is the labeler?

GlaxoSmithKline Biologicals SA, NDC labeler code 58160. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Shingrix?

2 other product NDCs are listed under this name. See all Shingrix NDCs.

Is there a related HCPCS / J-code?

Yes: 90750, Vaccine product code for SHINGRIX (zoster vaccine recombinant, adjuvanted). See Billing references above.

Related NDCs: other Shingrix products

Other finished products listed under the same name: strengths, forms and labelers.

Other NDCs under BLA 125614

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.